Director, Division of Pediatric Neurology, Department of Pediatric, Montreal Children’s Hospital
Associate Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre
NMD4C Working Group(s): Knowledge TranslationEmail Maryam
Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Clinician Scientist and Director of Pediatric Neurology at the Montreal Children’s Hospital. She is a Senior Clinical Research Scholar of the FRQ-S with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR.
Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. As part of NMD4C, she is developing clinical guidelines through the Knowledge Translation Team. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and chairing the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec.
Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University.
Mouchet, J, Roumpanis, S, Gaki, E, Lipnick, S, Oskoui, M, Scalco, RS et al.. Disease Burden of Spinal Muscular Atrophy: A Comparative Cohort Study Using Insurance Claims Data in the USA. J Neuromuscul Dis. 2022. PMID:36314213
Marefi, A, Husein, N, Dunbar, M, Dewey, D, Letourneau, N, Oskoui, M et al.. Risk Factors for Term-Born Periventricular White Matter Injury in Children With Cerebral Palsy: A Case-Control Study. Neurology. 2022. PMID:36041870
McIntyre, S, Goldsmith, S, Webb, A, Ehlinger, V, Hollung, SJ, McConnell, K et al.. Global prevalence of cerebral palsy: A systematic analysis. Dev Med Child Neurol. 2022.64 (12)1494-1506 PMID:35952356
Huroy, M, Behlim, T, Andersen, J, Buckley, D, Fehlings, D, Kirton, A et al.. Stability of the Gross Motor Function Classification System over time in children with cerebral palsy. Dev Med Child Neurol. 2022.64 (12)1487-1493 PMID:35941090
Markati, T, Oskoui, M, Farrar, MA, Duong, T, Goemans, N, Servais, L et al.. Emerging therapies for Duchenne muscular dystrophy. Lancet Neurol. 2022.21 (9)814-829 PMID:35850122See more on PubMed